| Bioactivity | DRI-C25441 is a potent blocker of CD40 and CD40L interaction, with an IC50 of 0.36 μM. DRI-C25441 can inhibit the immune response induced by alloantigen[1]. |
| Name | DRI-C25441 |
| CAS | 2101765-83-5 |
| Formula | C31H21N3O6 |
| Molar Mass | 531.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lu H, et, al. Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials. Signal Transduct Target Ther. 2020 Sep 23;5(1):213. |
DRI-C25441
CAS: 2101765-83-5 F: C31H21N3O6 W: 531.51
DRI-C25441 is a potent blocker of CD40 and CD40L interaction, with an IC50 of 0.36 μM. DRI-C25441 can inhibit the immu
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.